EPOW
E-Power Inc. Class A
There isn't enough reported data to score EPOW yet.
VRT
Vertiv Holdings Co
VRT's fundamentals are strong and it looks cheap: trading at 39x earnings, about half its usual 72x. Analysts expect strong earnings growth.
EPOW Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
EPOW's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
EPOW PE Valuation
EPOW has no meaningful PE right now: it lost money over the past year.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
EPOW Forward outlook
There aren't enough analyst estimates for EPOW to show an outlook.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
EPOW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$14.25 | -$2.25 |
| Q2 2025 | -$8.00 | +$19.00 |
| Q4 2024 | -$12.00 | +$15.00 |
| Q2 2024 | -$27.00 | -$5.00 |
| Q4 2023 | -$27.00 | -$2.50 |
EPOW is still losing money, but less than at its worst: $14.25 per share over the past year, against $27.00 at its worst in late 2023.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over EPOW in the latest year-over-year earnings comparison.
EPOW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $18.4M | -57% |
| Q2 2025 | $28M | +26% |
| Q4 2024 | $42.7M | +75% |
| Q2 2024 | $22.3M | +7.6% |
| Q4 2023 | $24.3M | -13% |
| Q2 2023 | $20.7M | +102% |
| Q4 2022 | $27.9M | +276% |
| Q4 2021 | $7.4M | -68% |
EPOW's revenue is growing: $18M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -83% | +20 points |
| Q2 2025 | -2.4% | +24 points |
| Q4 2024 | -26% | +23 points |
| Q2 2024 | -24% | +26 points |
| Q4 2023 | -103% | -3.1 points |
| Q2 2023 | -26% | -90 points |
| Q4 2022 | -49% | -118 points |
| Q2 2022 | -50% | -92 points |
EPOW's operating margin was −83% last quarter, up 20 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over EPOW in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT's operating margin was 23% last quarter, up 3.5 points from the same quarter a year ago, near the top of its range since 2020.
EPOW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$6.7M | -5857% |
| Q2 2025 | -$24.9M | -$16.9M |
| Q4 2024 | $116K | +$6.3M |
| Q2 2024 | -$7.9M | -$1.4M |
| Q4 2023 | -$6.2M | +$41.5M |
| Q2 2023 | -$6.6M | -$934.9K |
| Q4 2022 | -$47.6M | -$42.3M |
| Q4 2021 | -$5.3M | -204% |
EPOW has burned cash in most quarters: −$39M over the past year, against −$66M the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.
EPOW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.6% | +82.3K shares |
| 1 year | +13% | +137K shares |
| 3 years | +72% | +488K shares |
EPOW has 1M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
| Q2 2019 | — |
| Q4 2018 | — |
| Q2 2018 | — |
| Q2 2017 | — |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has the edge over EPOW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
EPOW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2020 | -0.6x | Net Cash |
EPOW has more cash than debt.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
EPOW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 9.6 | Oversold |
EPOW's weekly RSI is 30 (neutral) and its Stochastic is 10 (oversold).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
EPOW PE vs Industrials Sector
| Metric | EPOW | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
EPOW has no meaningful PE right now: it lost money over the past year.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
EPOW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.88 | 13% below |
| 20 week MA | $8.55 | 60% below |
| 50 week MA | $15.5 | 78% below |
| 100 week MA | $19.9 | 83% below |
| 200 week MA | $29.1 | 88% below |
EPOW is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has the edge over EPOW on trend strength, trading above more of its moving averages.
EPOW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $123.8 | $34.0 | -73% |
| 2022 | $34.0 | $77.0 | +126% |
| 2023 | $77.0 | $27.0 | -65% |
| 2024 | $27.0 | $20.7 | -23% |
| 2025 | $20.7 | $24.8 | +20% |
| 2026 YTD | $24.8 | $3.38 | -86% |
EPOW's yearly returns have swung widely, from +126% in 2022 to −73% in 2021. It's down 86% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over EPOW on returns for 2026, with the stronger performance.